MAP3K7 Loss of Function Causes Dilated Cardiomyopathy

Authors:
Preprint
Publisher website
Google Scholar
Abstract
Background and Aims: Dilated cardiomyopathy (DCM) is a genetically heterogeneous cause of heart failure and sudden cardiac death. Many patients remain without a molecular diagnosis. MAP3K7 encodes TAK1, a serine/threonine kinase important for cardiac homeostasis . MAP3K7 variants are an established cause of syndromic disease, including cardiospondylocarpofacial syndrome (CSCF), in which DCM has been occasionally reported. Here, we demonstrate that MAP3K7 variants can cause apparently isolated DCM, expanding the phenotypic spectrum of MAP3K7 -related disorders. Methods: We integrated four lines of genetic evidence: de novo variation, common variant association, familial segregation, and rare variant enrichment, alongside functional characterisation. Results: In 117 paediatric cardiomyopathy trios from the 100,000 Genomes Project, two probands harboured rare de novo MAP3K7 missense variants, significantly more than expected (Bonferroni-adjusted p=0.036). Independent GWAS implicated MAP3K7 as a susceptibility locus for adult DCM. Across global DCM cohorts, we identified families harbouring rare MAP3K7 variants, including one with segregation in nine affected relatives (p.(Tyr125Cys), estimated LOD = 2.7). Rare damaging non-truncating variants were enriched in DCM versus INTERVAL (OR 22, P=0.007) and gnomAD controls (OR 14, P=6.2×10⁻⁴), while truncating variants were associated with DCM in Genomics England and increased left ventricular volumes in UK Biobank. DCM-associated variants reduced TAK1 kinase activity, supporting a loss-of-function mechanism consistent with CSCF-associated alleles. Conclusion: Multiple independent lines of evidence establish an association between MAP3K7 loss of function variants and DCM. Several affected individuals lacked overt syndromic features, demonstrating that MAP3K7 -related disease may present as apparently isolated DCM across the lifespan and supporting inclusion of MAP3K7 in DCM diagnostic pipelines. GRAPHICAL Key Question: Do MAP3K7 variants cause isolated dilated cardiomyopathy?: MAP3K7 variants are known to cause rare syndromic disease, including cardiospondylocarpofacial syndrome (CSCF). Some patients with CSCF develop dilated cardiomyopathy (DCM), however we do not know whether MAP3K7 variants cause primary or isolated DCM without overt syndromic disease. Key Finding: We present multiple orthogonal data sources supporting an association between MAP3K7 loss-of-function variants and DCM. The collective evidence for this gene-disease association encompasses paediatric trio de novo discovery, GWAS, familial segregation, rare variant case-control analysis and variant categorisation in vitro . Strong segregation evidence was obtained for p.(Tyr125Cys), with nine clinically affected genotype-positive individuals in one pedigree (estimated LOD score 2.7). Further, p.(Cys266del) was observed in three affected individuals in one family and a de novo paediatric case. Take-Home Message: Loss-of-function variants in MAP3K7 are associated with DCM and several affected individuals lack overt syndromic features. MAP3K7 -related disease may present as apparently isolated DCM across the lifespan. These findings support the incorporation of MAP3K7 testing into DCM diagnostic pipelines.
Funding Information
  • Medical Research Future Fund (MRFF) Genomics Health Futures Mission (2032931)
  • National Health and Medical Research Council (2009982)
  • Medical Research Future Fund (EPCD000028)
  • National Health and Medical Research Council (1113531)
  • National Health and Medical Research Council (2000001)
  • MRFF Cardiovascular Health Mission (2024269)
  • Sir Jules Thorn Charitable Trust (21JTA)
  • Wellcome Trust (222883/Z/21/Z)
  • Wellcome Trust (222883/Z/21/Z)
  • Medical Research Council (MC_UP_1605/13)
  • British Heart Foundation (SP/17/11/32885)
  • British Heart Foundation (FS/CRLF/21/23011)
  • British Heart Foundation (BBC/F/21/220106)
  • British Heart Foundation (RE/24/130023)
  • British Heart Foundation (FS/IPBSRF/22/27059)
  • British Heart Foundation (RG/F/24/110138)
  • British Heart Foundation (CH/F/24/90015)
  • British Heart Foundation (FS/ICRF/24/26128)
  • Rosetrees Trust, Pathfinder Cardiogenomics programme of the European Innovation Council of the European Union (101115416)
  • Royal Brompton & Harefield Hospitals Charity
  • NIHR Imperial Biomedical Research Centre

This publication has 46 references indexed in Scilit: